methysergide has been researched along with fluoxetine in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (57.58) | 18.7374 |
1990's | 8 (24.24) | 18.2507 |
2000's | 4 (12.12) | 29.6817 |
2010's | 2 (6.06) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamblin, MW; Monsma, FJ; Shen, Y; Sibley, DR; Ward, RP | 1 |
Baumann, MH; Hufeisen, SJ; McBride, A; Rauser, L; Roth, BL; Rothman, RB; Savage, JE | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Gala, RR; Lawson, DM | 1 |
Herbert, DC; Morgan, WW | 1 |
Bryce, GF; Jacoby, JH | 1 |
Tseng, LF | 1 |
Baldwin, F; Hertz, L; Schousboe, A | 1 |
Jørgensen, H; Knigge, U; Warberg, J | 1 |
Meyer, EC; Sommers, DK; van Wyk, M | 1 |
Hilaire, G; Monteau, R; Morin, D | 1 |
Kleven, MS; Sparber, SB | 1 |
DeNoble, VJ; Spencer, KR; Strek, KF | 1 |
Allen, JM; Fairweather, I; Halton, DW; McKay, DM | 1 |
Burke, WH; el Halawani, ME; Fehrer, SC; Silsby, JL | 1 |
Facchinetti, F; Genazzani, AR; Martignoni, E; Nappi, G; Petraglia, F; Volpe, A | 1 |
El Halawani, ME; Fehrer, SC; Silsby, JL | 1 |
McElroy, JF; Meyer, JS; Miller, JM | 1 |
Larson, AA; Wilcox, GL | 1 |
Coppings, RJ; Giachetti, A; Krulich, L; Mayfield, MA; McCann, SM | 1 |
Bhargava, AK; Hudecki, MS; Hudecki, RS; Pollina, CM | 1 |
Carlà, V; Galli, A; Magnani, M; Sgaragli, G | 1 |
Broitman, ST; Fóscolo, MR; Rodríguez Echandía, EL | 1 |
Leccese, AP; Lyness, WH | 1 |
Aprison, MH; Hingtgen, JN; Nagayama, H | 1 |
Akunne, HC; Soliman, KF | 1 |
Fisher, H; Lu, MR; Wagner, GC | 1 |
Moncrieff, J; Sommers, DK; van Wyk, M | 1 |
Herges, S; Taylor, DA | 1 |
Amelin, AV; Ignatov, IuD; Skoromets, AA | 1 |
Calixto, JB; Dias Elpo Zomkowski, A; Lin, J; Lúcia Severo Rodrigues, A; Oscar Rosa, A; Santos, AR | 1 |
Dilks, JR; Flaumenhaft, R | 1 |
Friedman, A; Heinemann, U; Melamed-Book, N; Ofek, K; Schoknecht, K; Soreq, H | 1 |
1 review(s) available for methysergide and fluoxetine
Article | Year |
---|---|
[Current views on migraine and anti-migraine preparations].
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Antidepressive Agents; Aza Compounds; Brain; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Clonidine; Fluoxetine; Humans; Imidazoles; Maprotiline; Methysergide; Migraine Disorders; Mutation; Pizotyline; Placebos; Propranolol; Research; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sympatholytics; Vasoconstrictor Agents | 2003 |
3 trial(s) available for methysergide and fluoxetine
Article | Year |
---|---|
Effects of enhancement and antagonism of 5-hydroxytryptamine activity on metoclopramide-induced aldosterone secretion in man.
Topics: Acetylcholine; Adult; Aldosterone; Fluoxetine; Humans; Male; Metergoline; Methysergide; Metoclopramide; Pizotyline; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1991 |
Serotoninergic agonists increase plasma levels of beta-endorphin and beta-lipotropin in humans.
Topics: 5-Hydroxytryptophan; Adrenocorticotropic Hormone; Adult; beta-Endorphin; beta-Lipotropin; Endorphins; Fluoxetine; Humans; Hydrocortisone; Male; Methysergide; Radioimmunoassay; Serotonin | 1984 |
Effects of enhancement and antagonism of 5-hydroxytryptamine activity on the influence of metoclopramide on gastric emptying.
Topics: Acetaminophen; Adult; Fluoxetine; Gastric Emptying; Humans; Male; Metergoline; Methysergide; Metoclopramide; Pizotyline; Premedication; Receptors, Serotonin; Serotonin; Single-Blind Method; Time Factors | 1993 |
29 other study(ies) available for methysergide and fluoxetine
Article | Year |
---|---|
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain Chemistry; Cell Line; Cloning, Molecular; DNA; GTP-Binding Proteins; Lysergic Acid Diethylamide; Molecular Sequence Data; Polymerase Chain Reaction; Psychotropic Drugs; Rats; Receptors, Serotonin; RNA; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 1993 |
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
Topics: Dose-Response Relationship, Drug; Ergotamine; Fenfluramine; Heart Valve Diseases; Humans; Methylergonovine; Norfenfluramine; Receptors, Serotonin; Serotonin Antagonists | 2000 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
Topics: 5-Hydroxytryptophan; Animals; Castration; Estrogens; Female; Fluoxetine; Kinetics; Methysergide; Prolactin; Quinolines; Quipazine; Rats; Serotonin | 1978 |
Elevation of serum prolactin levels after the inhibition of serotonin uptake.
Topics: Aging; Animals; Diencephalon; Fluoxetine; Hydroxyindoleacetic Acid; Male; Methysergide; Prolactin; Propylamines; Rats; Serotonin | 1978 |
The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
Topics: 5-Hydroxytryptophan; Animals; Blood Glucose; Dose-Response Relationship, Drug; Fluoxetine; Glucagon; Insulin; Insulin Secretion; Male; Methysergide; Phentolamine; Propranolol; Propylamines; Quinolines; Quipazine; Rats | 1979 |
Hydroxytryptamine uptake inhibitors block para- methoxyamphetamine-induced 5-HT release.
Topics: Amphetamines; Animals; Clomipramine; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Male; Methysergide; Muscle Contraction; Pargyline; Rats; Serotonin | 1979 |
Serotonin receptors on astrocytes in primary cultures: effects of methysergide and fluoxetine.
Topics: Animals; Astrocytes; Cells, Cultured; Fluoxetine; Methysergide; Mice; Propylamines; Protein Binding; Receptors, Serotonin | 1979 |
Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Dose-Response Relationship, Drug; Ergolines; Fluoxetine; Imidazoles; Indoles; Ketanserin; Male; Methysergide; Ondansetron; Prolactin; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tropisetron | 1992 |
5-Hydroxytryptamine modulates central respiratory activity in the newborn rat: an in vitro study.
Topics: Animals; Animals, Newborn; Brain Stem; Electric Stimulation; Fenclonine; Fluoxetine; In Vitro Techniques; Medulla Oblongata; Methysergide; Rats; Respiration; Serotonin; Serotonin Antagonists; Spinal Cord; Tryptophan | 1991 |
Modification of quasi-morphine withdrawal with serotonin agonists and antagonists: evidence for a role of serotonin in the expression of opiate withdrawal.
Topics: 1-Methyl-3-isobutylxanthine; 5-Hydroxytryptophan; Animals; Fluoxetine; Male; Methysergide; Mianserin; Morphine; Piperidines; Rats; Serotonin; Serotonin Antagonists; Substance Withdrawal Syndrome | 1989 |
Manipulation of serotonin protects against an hypoxia-induced deficit of a passive avoidance response in rats.
Topics: Animals; Avoidance Learning; Cyproheptadine; Dose-Response Relationship, Drug; Fluoxetine; Hypoxia; Ketanserin; Male; Methysergide; Mianserin; Rats; Rats, Inbred Strains; Serotonin; Zimeldine | 1989 |
The effects of cholinergic and serotoninergic drugs on motility in vitro of Haplometra cylindracea (Trematoda: Digenea).
Topics: Acetylcholine; Animals; Atropine; Carbachol; Fluoxetine; Methysergide; Movement; Nicotine; Parasympathomimetics; Physostigmine; Rana temporaria; Reserpine; Serotonin; Serotonin Antagonists; Trematoda; Tubocurarine | 1989 |
The influence of pharmacological manipulation of serotonin on serum growth hormone and luteinizing hormone levels in young turkeys (Meleagris gallopavo).
Topics: 5-Hydroxytryptophan; Animals; Female; Fluoxetine; Growth Hormone; Luteinizing Hormone; Male; Methysergide; Quipazine; Radioimmunoassay; Serotonin; Turkeys | 1985 |
Serotonergic stimulation of prolactin release in the young turkey (Meleagris gallopavo).
Topics: 5-Hydroxytryptophan; Animals; Dose-Response Relationship, Drug; Female; Fluoxetine; Injections, Intraperitoneal; Methysergide; Prolactin; Propylamines; Quinolines; Quipazine; Radioimmunoassay; Serotonin; Stimulation, Chemical; Turkeys | 1983 |
Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
Topics: Adrenocorticotropic Hormone; Amphetamines; Animals; Corticosterone; Fenfluramine; Fluoxetine; Male; Methysergide; p-Chloroamphetamine; Pituitary-Adrenal System; Rats; Receptors, Serotonin; Serotonin | 1984 |
Synergistic behavioral effects of serotonin and tryptamine injected intrathecally in mice.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Injections, Spinal; Male; Methysergide; Mice; Serotonin; Tryptamines | 1984 |
Lack of evidence that the central serotoninergic system plays a role in the activation of prolactin secretion following inhibition of dopamine synthesis or blockade of dopamine receptors in the male rat.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Cyproheptadine; Depression, Chemical; Dopamine; Dopamine Antagonists; Fenclonine; Fluoxetine; Flupenthixol; Hypothalamus; Male; Methysergide; Prolactin; Rats; Receptors, Dopamine; Receptors, Serotonin; Spiperone; Stimulation, Chemical; Tyrosine | 1980 |
Screening of antiserotoninergic drugs with the genetically dystrophic chicken.
Topics: Animals; Aspartate Aminotransferases; Chickens; Creatine Kinase; Drug Evaluation, Preclinical; Ergonovine; Female; Fenclonine; Fluoxetine; L-Lactate Dehydrogenase; Male; Methiothepin; Methysergide; Muscular Dystrophy, Animal; Nortriptyline; Penicillamine; Serotonin Antagonists | 1980 |
Hypothermia induced in rabbits by intracerebroventricular taurine: specificity and relationships with central serotonin (5-HT) systems.
Topics: Animals; Body Temperature Regulation; Brain Chemistry; Clomipramine; Fenclonine; Fever; Fluoxetine; Injections, Intraventricular; Male; Methysergide; Rabbits; Serotonin; Serotonin Antagonists; Skin Temperature; Taurine | 1981 |
Effects of the chronic ingestion of therapeutic doses of chlorimipramine on the behavioral action of agonists and antagonists of serotonin in male rats.
Topics: 5-Hydroxytryptophan; Animals; Clomipramine; Exploratory Behavior; Fluoxetine; Male; Methysergide; Motor Activity; Myoclonus; Propylamines; Rats; Serotonin | 1983 |
The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions.
Topics: 5,7-Dihydroxytryptamine; Animals; Cyproheptadine; Dextroamphetamine; Fluoxetine; Humans; Male; Medial Forebrain Bundle; Methysergide; Neural Pathways; Quipazine; Rats; Rats, Inbred Strains; Serotonin; Substance-Related Disorders; Tryptophan | 1984 |
Pre- and postsynaptic serotonergic manipulations in an animal model of depression.
Topics: 5-Hydroxytryptophan; Amitriptyline; Animals; Depression; Disease Models, Animal; Drug Synergism; Fluoxetine; Humans; Male; Methysergide; Propylamines; Rats; Serotonin | 1980 |
Serotonin modulation of pain responsiveness in the aged rat.
Topics: Aging; Animals; Drug Synergism; Fluoxetine; Male; Methysergide; Morphine; Pain; Pain Measurement; Rats; Rats, Inbred F344; Reaction Time; Serotonin | 1994 |
Ethanol consumption following acute treatment with methysergide, fluoxetine, fenfluramine, and their combination.
Topics: Alcohol Drinking; Animals; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Male; Methysergide; Rats; Rats, Sprague-Dawley; Serotonin; Synaptic Transmission | 1994 |
Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat.
Topics: Animals; Behavior, Animal; Cocaine; Drug Interactions; Female; Fluoxetine; Ketanserin; Methysergide; Motor Activity; Narcotics; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1998 |
Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test.
Topics: Agmatine; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Female; Fenclonine; Fluoxetine; Immobility Response, Tonic; Male; Methysergide; Mice; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 2004 |
Fluoxetine (Prozac) augments platelet activation mediated through protease-activated receptors.
Topics: Adenine; Antigens, CD; Blood Platelets; Cytoplasmic Granules; Drug Synergism; Fluoxetine; Humans; Methysergide; Oligopeptides; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Membrane Glycoproteins; Receptor, PAR-1; Receptor, Serotonin, 5-HT2A; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Receptors, Thrombin; Selective Serotonin Reuptake Inhibitors; Serotonin; Tetraspanin 30; Thrombin; Valerates | 2008 |
Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signalling.
Topics: Acetylcholinesterase; Animals; Arterioles; Atropine; Calcium; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; HSP90 Heat-Shock Proteins; Male; Mecamylamine; Methysergide; Muscarinic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Reperfusion; Selective Serotonin Reuptake Inhibitors; Serotonin; Signal Transduction; Stroke; Vasodilation | 2012 |